Endovascular Engineering

Endovascular Engineering develops and deploys advanced clot removal solutions for the treatment of venous thromboembolism.

Health and bioDeveloper tools and cloud

TIMELINE · MONEY RAISED

Endovascular Engineering | 1681 days on the record

Raised $137M in 3 sourced rounds

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. April 7, 2026
   Series B+ · $80M
   GGilde Healthcare (lead), NNorwest Venture Partners (lead), 4415 Capital, MM&L Healthcare Investments, PPanakes Partners, SS3 Ventures, SSante Ventures
   Source: finsmes.com
2. March 9, 2025
   Series B+ · $42M
   4415 Capital (lead), SS3 Ventures (lead), CCordis, MM&L Healthcare Investments, PPanakes Partners, SSante Ventures
   Source: startupintros.com
3. April 6, 2022
   Series A · $15M
   CCordis (lead), SSante Ventures (lead)
   Source: startupintros.com
4. February 19, 2019
   Website created

Founders and team

• LS
  Luis Savastano Founder

  @SavastanoLuisMD · LinkedIn
• MR
  Mike Rosenthal Founder

  LinkedIn
• DR
  Dan Rose CEO
• JF
  Justin Farry Chief Financial Officer

Investors

• 4415 Capitallead investor
• CCordislead investor
• GGilde Healthcarelead investor
• MM&L Healthcare Investments
• NNorwest Venture Partnerslead investor
• PPanakes Partners
• SS3 Ventureslead investor
• SSante Ventureslead investor

Companies like Endovascular Engineering

• KKoya Medical$30M Series B+ · Nov 2023
• TThruFlo EndovascularSeed · Jun 2026
• HHaptena Therapeutics$3.53M Seed · Dec 2025
• MMerida Biosciences$120M Series A · May 2025
• MModulo Bio$4.8M Seed · Mar 2025
• TTreewaterSeed · Sep 2026

Other companies backed by Gilde Healthcare

• SSidera Bio$109.99M Series A · Nov 2025
• PProVerum$80M Series B+ · Aug 2025
• SSplice Bio$140M Series B+ · Jun 2025
• CCatalYm$150M Series B+ · Jul 2024
• AArgá Medtech$58.72M Series B+ · Feb 2024
• TTagworks Pharmaceuticals$65M Series A · Jun 2023

Gilde Healthcare portfolio →